Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
Fossat C, Roussel M, Arnoux I, Asnafi V, Brouzes C, Garnache-Ottou F, Jacob MC, Kuhlein E, Macintyre-Davi E, Plesa A, Robillard N, Tkaczuk J, Ifrah N, Dombret H, Béné MC, Baruchel A, Garand R; French Multicenter Study Groups for Pediatric and Adult ALL. Fossat C, et al. Among authors: robillard n. Cytometry B Clin Cytom. 2015 Jan;88(1):21-9. doi: 10.1002/cyto.b.21195. Epub 2014 Nov 1. Cytometry B Clin Cytom. 2015. PMID: 25363877 Free article. Clinical Trial.
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.
Garand R, Beldjord K, Cavé H, Fossat C, Arnoux I, Asnafi V, Bertrand Y, Boulland ML, Brouzes C, Clappier E, Delabesse E, Fest T, Garnache-Ottou F, Huguet F, Jacob MC, Kuhlein E, Marty-Grès S, Plesa A, Robillard N, Roussel M, Tkaczuk J, Dombret H, Macintyre E, Ifrah N, Béné MC, Baruchel A. Garand R, et al. Among authors: robillard n. Leukemia. 2013 Feb;27(2):370-6. doi: 10.1038/leu.2012.234. Epub 2012 Aug 16. Leukemia. 2013. PMID: 23070018
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
Fossat C, Roussel M, Arnoux I, Asnafi V, Brouzes C, Garnache-Ottou F, Jacob MC, Kuhlein E, Macintyre-Davi E, Plesa A, Robillard N, Tkaczuk J, Ifrah N, Dombret H, Béné MC, Baruchel A, Garand R; for the French Multicenter Study Groups for Pediatric and Adult ALL. Fossat C, et al. Among authors: robillard n. Cytometry B Clin Cytom. 2014 Oct 1. doi: 10.1002/cytob.21195. Online ahead of print. Cytometry B Clin Cytom. 2014. PMID: 25270227 Free article.
CD180 expression in B-cell lymphomas: A multicenter GEIL study.
Mayeur-Rousse C, Guy J, Miguet L, Bouyer S, Geneviève F, Robillard N, Solly F, Maar A, Bené MC, Mauvieux L; GEIL (Groupe d'Etude Immunologique des Leucémies). Mayeur-Rousse C, et al. Among authors: robillard n. Cytometry B Clin Cytom. 2016 Sep;90(5):462-6. doi: 10.1002/cyto.b.21325. Epub 2015 Oct 6. Cytometry B Clin Cytom. 2016. PMID: 26384474 Free article.
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.
Solly F, Angelot-Delettre F, Ticchioni M, Geneviève F, Rambaud H, Baseggio L, Plesa A, Debliquis A, Garnache-Ottou F, Roggy A, Campos L, Aanei C, Rosenthal-Allieri A, Georget MT, Lachot S, Jacob MC, Robillard N, Wuilleme S, Andre-Kerneis E, Cornet E, Salaun V, Bennami H, Lhoumeau AC, Arnoulet C, Jacqmin H, Neyman N, Latger-Cannard V, Massin F, Lainey E, Le Garff-Tavernier M, Costopoulos M, Roussel M, Mayeur-Rousse C, Eischen A, Raggeneau V, Derrieux C, Maurer M, Asnafi V, Trinquand A, Brouzes C, Lhermitte L. Solly F, et al. Among authors: robillard n. Cytometry A. 2019 Sep;95(9):1008-1018. doi: 10.1002/cyto.a.23844. Epub 2019 Jul 31. Cytometry A. 2019. PMID: 31364809 Free article.
Flow cytometry in hematological nonmalignant disorders.
Béné MC, Le Bris Y, Robillard N, Wuillème S, Fouassier M, Eveillard M. Béné MC, et al. Among authors: robillard n. Int J Lab Hematol. 2016 Feb;38(1):5-16. doi: 10.1111/ijlh.12438. Epub 2015 Nov 6. Int J Lab Hematol. 2016. PMID: 26542092 Review.
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study.
Chevallier P, Huguet F, Raffoux E, Etienne A, Leguay T, Isnard F, Robillard N, Guillaume T, Delaunay J, Charbonnier A, Pigneux A, Peterlin P, Bené MC, Wegener WA, Goldenberg DM, Dombret H. Chevallier P, et al. Among authors: robillard n. Haematologica. 2015 Apr;100(4):e128-31. doi: 10.3324/haematol.2014.120220. Epub 2014 Dec 31. Haematologica. 2015. PMID: 25552705 Free PMC article. Clinical Trial. No abstract available.
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
Chevallier P, Eugene T, Robillard N, Isnard F, Nicolini F, Escoffre-Barbe M, Huguet F, Hunault M, Marcais A, Gaschet J, Cherel M, Guillaume T, Delaunay J, Peterlin P, Eveillard M, Thomas X, Ifrah N, Lapusan S, Bodet-Milin C, Barbet J, Faivre-Chauvet A, Ferrer L, Bene MC, Le Houerou C, Goldenberg DM, Wegener WA, Kraeber-Bodéré F. Chevallier P, et al. Among authors: robillard n. Lancet Haematol. 2015 Mar;2(3):e108-17. doi: 10.1016/S2352-3026(15)00020-4. Epub 2015 Feb 25. Lancet Haematol. 2015. PMID: 26687796 Clinical Trial.
145 results